Calidi Biotherapeutics, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
4475 EXECUTIVE DRIVE, SAN DIEGO, CA, 92121
Mailing Address
4475 EXECUTIVE DRIVE, SAN DIEGO, CA, 92121
Phone
858-794-9600
Fiscal Year End
1231
EIN
862967193
Financial Overview
FY2025
$14.18M
Total Assets
$12.21M
Total Liabilities
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 2, 2026 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | March 31, 2026 | View on SEC |
| 8-K Current report of material events | March 27, 2026 | View on SEC |
| 10-K Annual financial report | March 27, 2026 | View on SEC |
| 8-K Current report of material events | March 11, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 9, 2026 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | March 9, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 6, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 10, 2026 | View on SEC |
| 8-K Current report of material events | February 10, 2026 | View on SEC |
Annual Reports
10-K
March 27, 2026
- Advancing Phase 1 clinical trial for CLD-101 brain cancer treatment
- Successfully completed merger with First Light Acquisition Group to secure capital
Insider Trading
SELL
1 insiders
1 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
NEUROCRINE BIOSCIENCES INC
NBIX
Biological Products, (No Diagnostic Substances)
Vor Biopharma Inc.
VOR
Biological Products, (No Diagnostic Substances)
Replimune Group, Inc.
REPL
Biological Products, (No Diagnostic Substances)
BioAtla, Inc.
BCAB
Biological Products, (No Diagnostic Substances)
Vericel Corp
VCEL
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.